Report Code: A13359 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Genital herpes is an infectious disease which is caused due to Herpes Simplex Virus of the genitals. Most of the people who suffer from this infection either have no symptoms or mild symptoms. Common symptoms include small blisters that break open and form ulcers at particular area. Moreover, flu like symptoms such as fever, aching, and swollen lymph nodes can be observed. Drugs such as Acyclovir and Famciclovir are used treatment of genital herpes. These medications help to prevent herpes sores & blisters. Moreover, these drugs can be used in the treatment of outbreak of genital herpes and to reduce future complications.
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the genital herpes treatment market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, OrganiCare announced launch of its new product FemiClear. This medication is over the counter and used in treatment of genital herpes symptoms.
In 2020, Perrigo announced launch of its AB rated generic Zovirax cream. This product content acyclovir and can used to reduce further complications in genital herpes.
Key Benefits of the Report
Questions Answered in the Genital Herpes Treatment Market Report  Â
Genital Herpes Treatment Market Report Highlights
Aspects | Details |
---|---|
By Drug Type |
|
By Route of Administration |
|
By Indication |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Hospira Inc., Novopharm Ltd., Mylan Pharmaceuticals Inc., GlaxoSmithKline, Maruho, Vical, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceuticals Inc, Novartis AG, Sandoz Inc., AiCuris, Apotheca Inc., Genocea Biosciences |
Loading Table Of Content...
Start reading.
This Report and over 71,251+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers